Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Trending Product / SARS-CoV-2

Recombinant SARS-CoV-2 E Protein, N-His-SUMO

Catalog #:   YVV00601 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P0DTC4
Protein length: Met1-Val47
Overview

Catalog No.

YVV00601

Expression system

E. coli

Species

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Protein length

Met1-Val47

Predicted molecular weight

21.04 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P0DTC4

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Envelope small membrane protein, E, sM protein, E Protein

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant SARS-CoV-2 E Protein protein
References

Dynamic ensembles of SARS-CoV-2 N-protein reveal head-to-head coiled-coil-driven oligomerization and phase separation., PMID:40503686

Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2., PMID:40500288

IL-6 as a Mediator of Platelet Hyper-Responsiveness., PMID:40497942

Dynamics of Innate Immunity in SARS-CoV-2 Infections: Exploring the Impact of Natural Killer Cells, Inflammatory Responses, Viral Evasion Strategies, and Severity., PMID:40497938

Long COVID-19 autoantibodies and their potential effect on fertility., PMID:40496870

Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry., PMID:40483334

Ashwagandha, Withania somnifera (L.) Dunal, for the prophylaxis against SARS-CoV-2 infection: A multicentric randomized hydroxychloroquine controlled clinical trial in Indian health care workers., PMID:40482293

Cytokine profiling in COVID-19 patients by using ion mobility-mass spectrometry-based parallel reaction monitoring., PMID:40480698

Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered Spike localization and increased cell-to-cell transmission., PMID:40475451

No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations., PMID:40473598

COVID-19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune-Virological Features., PMID:40470910

Adaptation of PCR-based library preparation for MGI platform for cancer mutation testing in clinical setting., PMID:40465654

Potential Inhibitors of SARS-CoV-2 Developed through Machine Learning, Molecular Docking, and MD Simulation., PMID:40464176

Synthesis and anti-SARS-CoV-2 potential of novel coumarin hybrids: a combined wet/dry lab approach targeting MPro, Nsp15 and spike protein., PMID:40463350

A Nanomaterial-Independent Biosensor Based on Gallium Arsenide High-Electron-Mobility Transistors for Rapid and Ultra-Sensitive Pathogen Detection., PMID:40461437

Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutations., PMID:40458889

Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 'Patria' vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version., PMID:40458417

MSBack: Multiscale Backmapping of Highly Coarse-Grained Proteins Using Constrained Diffusion., PMID:40452189

Asymptomatic SARS-CoV-2 Infection: Association Involving the HLA-B*15 Allele Group in Brazilian Individuals., PMID:40451247

SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model., PMID:40445428

Evidence of SARS-CoV-2 bacteriophage potential in human gut microbiota., PMID:40444030

Evaluation of combined BCG and SARS-CoV-2 vaccination for immune enhancement and lung protection in Syrian hamsters., PMID:40442229

Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity., PMID:40442110

Post-coronavirus Disease 2019 (COVID-19) Cardiovascular Manifestations: A Systematic Review of Long-Term Risks and Outcomes., PMID:40438846

Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection., PMID:40437072

Incidence of SARS-CoV-2 reinfection among blood donors from two Brazilian states in the post-vaccination period: a prospective cohort study., PMID:40435110

XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice., PMID:40432153

Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination., PMID:40432092

TREM-1-Linked Inflammatory Cargo in SARS-CoV-2-Stimulated Macrophage Extracellular Vesicles Drives Cellular Senescence and Impairs Antibacterial Defense., PMID:40431622

The Overlooked Nucleocapsid Response: A Cohort Study of SARS-CoV-2 Vaccines in Brazil., PMID:40430765

Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies., PMID:40430736

Efficient Searches in Protein Sequence Space Through AI-Driven Iterative Learning., PMID:40429882

Persistent Monocytic Bioenergetic Impairment and Mitochondrial DNA Damage in PASC Patients with Cardiovascular Complications., PMID:40429707

Rapid and Cost-Effective Diagnostic Blot Assays Based on the Use of Plant-Produced Recombinant Antigens: Lessons Learned from the SARS-CoV-2 RBD Antigen., PMID:40429644

Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations., PMID:40425752

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study., PMID:40418566

COVID-19 clinical outcomes and N-acetylcysteine (CoViNAC study): a GRADE compliant meta-analysis of randomized controlled trials with molecular docking and dynamics simulation studies with Mpro of SARS-CoV-2., PMID:40418545

Virus-specific host responses and gene signatures following infection with major SARS-CoV-2 variants of concern: role of ZBP1 in viral clearance and lung inflammation., PMID:40416961

Is SARS-CoV-2 Spike Evolution Being Retargeted at the N-Terminal Domain?, PMID:40415355

Laboratory markers among children with respiratory tract infection using a multiplex PCR test., PMID:40414104

Cross-reactive sarbecovirus antibodies induced by mosaic RBD nanoparticles., PMID:40402246

Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1)., PMID:40400480

Genome-wide association study of long COVID., PMID:40399555

Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study., PMID:40398499

SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19., PMID:40397714

The relationship between tryptophan metabolism and gut microbiota: Interaction mechanism and potential effects in infection treatment., PMID:40393170

The Impact of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen-E, Human Leukocyte Antigen-G Polymorphisms on Innate Immunity and COVID-19 Severity., PMID:40391199

Template-Based Docking Using Automated Maximum Common Substructure Identification with EnzyDock: Mechanistic and Inhibitor Docking., PMID:40388499

Establishment of a novel adjuvant screening system for the development of intranasal vaccine adjuvants., PMID:40383081

Science tikkun: a bioscience pandemic framework in a Hebrew tradition of global repair., PMID:40380137

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant SARS-CoV-2 E Protein, N-His-SUMO [YVV00601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only